Explore how suprachoroidal injection is a groundbreaking new macular degeneration treatment. Learn how it offers a safer, more targeted alternative to a traditional subretinal injection.
Learn about the latest advances in age-related macular degeneration (AMD) treatment, including a new drug that targets beta-amyloid to help prevent blindness and vision loss.
Promising new data shows that Factor H (CPV-104) significantly reduces inflammation and retinal degeneration in an animal model of dry age-related macular degeneration
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.